Tag Archives: neurological problems

Practical Tool Can ‘Take Pulse’ of Blue-Green Algae Status in Lakes

COLUMBUS, Ohio – Scientists have designed a screening tool that provides a fast, easy and relatively inexpensive way to predict levels of a specific toxin in lakes that are prone to blue-green algal blooms.

Blue-green algae is not your average pond scum – rather than consisting of plant-like organisms, blue-green algae actually are cyanobacteria, and some species are linked to the production and release of the toxin microcystin into the water. Human exposure to the toxin through drinking or recreational water contact can threaten public health by causing liver damage, neurological problems and gastrointestinal illness in humans. (more…)

Read More

What Makes Ticks Tick?

Durland Fish has researched ticks and their associated diseases for decades. A professor in the Division of Epidemiology of Microbial Diseases at the Yale School of Public Health, he has, among other things, contributed to the discovery that the bacterium that causes Lyme disease has European ancestry and that the disease, once nearly eradicated in North America, roared back with reforestation. More recently he helped develop a Lyme disease “app” for the iPhone and other Apple devices that provides users with detailed information about tick populations in any given area in the United States and even comes with a video on how to safely remove a tick. He has also worked on mosquito-borne West Nile virus and dengue fever. Students selected Fish as the school’s mentor of the year in 2010. (more…)

Read More

Lab Studies Show Promise for New Multiple Sclerosis Treatment

Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain, according to Distinguished Professor Linda Watkins of the University of Colorado at Boulder. 

Watkins and her colleagues in CU-Boulder’s department of psychology and neuroscience discovered that a single injection of a compound called ATL313 — an anti-inflammatory drug being developed to treat chronic pain — stopped the progression of MS-caused paralysis in rats for weeks at a time.  (more…)

Read More